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INTRODUCTION
BM suppression is one of the common side effects of radiotherapy and the primary cause of death after exposure to a moderate or high dose of TBI.
1,2 Acute BM suppression occurs within days after exposure to ionizing radiation (IR), primarily due to induction of apoptosis in the rapidly proliferating hematopoietic progenitor cells (HPCs TBI. Mice were exposed to a sublethal (6.0 Gy) dose of TBI in a Mark I 137 Ce γ -irradiator (JL Shepherd, Glendale, CA) at a rate of 2.4 Gy/min. Mice were irradiated on a rotating platform. Although TBI does not cause sustained quantitative reduction in HSCs, it induces longterm alterations in HSC functions. When measured by 4-and 6-week CAFCs, the frequencies of functional HSCs were significantly lower in BM cells from the irradiated mice than in those from normal controls (Figure 2A ). However, the frequencies of functional HPCs represented by 1-and 2-week CAFCs were relatively normal in BM cells from the irradiated mice, as compared to those from unirradiated controls (Figure 2A ). Furthermore, after transplantation into lethally irradiated recipients ( Figure 2B ), HSCs from irradiated mice exhibited significant functional defects compared to normal HSCs, including reduced ability to generate long-term donor cell engraftment and myeloid lineage skewing .
Isolation of BM mononuclear cells (BM-MNCs), lineage-negative hematopoietic cells (Lin
To determine whether the dysfunction of HSCs from irradiated animals is attributable to induction of HSC senescence by IR, the activity of SA-β-gal in HSCs and their progeny was directly measured by a newly developed SA-β-gal flow cytometric assay. As we showed previously, 8 increased SA-β-gal staining was found after TBI mainly in LSK cells but not in HPCs ( Figure 3A and Supplemental Figure 1 ). Further analysis revealed that more HSCs (particularly LT-HSCs) than MPPs were stained positive for SA-β-gal after TBI, indicating that increased SA-β-gal staining in LSK cells is primarily attributable to the induction of HSC senescence by IR. In contrast, no significant changes in apoptosis were found in HSCs from mice 2 months after TBI based on the results from the annexin V staining assay ( Figure 3B ). These findings suggest that TBI induced residual BM suppression, at least in part, via selective induction of HSC senescence. This suggestion is supported by the finding that irradiated HSCs expressed about 18-fold higher levels of p16 and 14-fold higher levels of Arf mRNA than did unirradiated HSCs ( Figure 3C ). Increased expression of p16 and Arf has been implicated in mediating induction of senescence in a variety of cells including HSCs and is the most robust biomarker of senescence cells besides SA-β-gal staining. 8, 24, 25 In addition, expression of p21 mRNA, but not that of p27 and p57 mRNA, was also moderately higher in HSCs from irradiated mice than in those from control mice. Increased expression of p21 also plays a role in induction of senescence, particularly during its initiation.
26
However, not all HSCs became senescent 2 months after TBI since only about 12% and 17% of HSCs and LSK cells from irradiated mice exhibited significant increases in SA-β-gal staining, respectively ( Figure 3A and Supplemental Figure 1 ), which was also confirmed by analysis of p16 and p21 mRNA expression at single cell level in HSCs as shown in Supplemental Figure 3D -F and Figure 4A -C, SA-β-gal + LSK cells expressed significant higher levels of p16, exhibited diminished ability to proliferate in vitro, and produced substantially lower levels of long-term engraftment after transplantation compared to SA-β-gal -LSK cells and LSK cells from control unirradiated mice. In addition, SA-β-gal -LSK cells from irradiated mice also expressed slightly higher levels of p16 and exhibited some deficiencies in their proliferative and repopulating functions in comparison with those of control unirradiated LSK cells.
TBI induces HSC senescence independent of telomere shortening
Induction of cellular senescence occurs as a result of extensive replication, which results in telomere shortening or occurs prematurely after cells are exposed to oxidative, genotoxic, or oncogenic stress. [27] [28] [29] Our previous studies suggest that IR induces HSC senescence primarily via induction of oxidative stress, 9,23,30 which may induce HSC senescence prematurely, via induction 1 1 of oxidative damage, or by increasing HSC cycling that results in telomere shortening. To investigate these possibilities, intracellular production of ROS in different populations of hematopoietic cell from irradiated mouse BM was compared with that from normal controls. As shown in Figure 5A and Supplemental Figure 3A , ROS production in HPCs and MPPs from irradiated mice was slightly higher (about 1.2-to 1.3-fold) than in cells from unirradiated mice.
However, after TBI, ROS production in irradiated HSCs including ST-HSCs and LT-HSCs was more than 1.7-fold higher than in respective un-irradiated control cell populations, confirming that TBI can selectively induce chronic oxidative stress in HSCs. The increased production of ROS in irradiated LT-HSCs was associated with a significant reduction in cell quiescence (e.g., fewer G 0 cells) and an increase in DNA synthesis (e.g., more BrdU-labeled cells) ( Figure 5B and C and Supplemental Figure 3B and C), indicating that LT-HSCs are highly responsive to ROSstimulated cell proliferation. Alternatively, increased cycling of irradiated LT-HSCs may represent a mechanism for non-senescent LT-HSCs to compensate for the loss of senescent LTHSCs after TBI; however, this increased cycling did not result in telomere shortening in HSCs and their progeny ( Figure 5D -F), providing key evidence that TBI induces HSC senescence in a telomere shortening-independent manner. These findings suggest that HSCs mainly undergo premature senescence after exposure to IR.
Knockout of p16 and/or Arf fails to protect HSCs from TBI-induced senescence
The p16-Arf locus encodes two tumor suppressors, p16 and Arf, 10,11 which have been implicated in mediating induction of cellular senescence in a variety of cells including HSCs.
Since increased expression of p16 and Arf was found in irradiated HSCs in association with elevated SA-β-gal activity and significantly reduced HSC function, we next examined whether Figure 6 and Supplemental Figures 4 and 5) . Two months after TBI, they also exhibited the same degrees of reductions in BM LSK cells and MPPs, with no significant changes in HPCs and HSCs, except p16 KO mice showed a significant reduction in HSCs after TBI, compared to unirradiated controls. Before exposure to TBI, BM cells from the KO mice also generated similar numbers of various CAFCs; after TBI, they exhibited comparable reductions in HSC clonogenicity, manifested by decreases in 4-and 6-week CAFCs, which were similar to those seen in cells from irradiated WT mice ( Figure 7A -C).
These findings suggest that p16 and Arf do not mediate induction of HSC senescence by TBI, even though TBI can upregulate their expression in HSCs.
This suggestion is further supported by the finding that similar numbers of BM ST-HSCs and LT-HSCs from both WT and p16-Arf KO mice became SA-β-gal + after TBI ( Figure 7D ), despite the fact that HSCs from p16-Arf KO mice express no detectable p16 and Arf mRNA (Supplemental Figure 6 ). In addition, when BM cells from irradiated p16 KO mice were transplanted into lethally irradiated recipients, they demonstrated defects in HSC function that was similar to those of cells from irradiated WT mice, including reduced long-term donor cell engraftment and myeloid lineage skewing (Figure 7 ). Because the BM cells from Arf and p16-Arf KO mice have a higher propensity of malignant transformation, particularly after TBI, we did not perform the competitive repopulation assay on irradiated BM cells from these mice.
Therefore, these data demonstrate that IR induces residual BM suppression and HSC senescence in a p16/Arf-independent manner. However, the molecular mechanisms by which ROS mediate the induction of HSC senescence by IR were unknown. The results from our current study suggest that ROS may mediate IR-induced HSC senescence in a telomere-independent manner, because increased production of ROS by irradiated HSCs was not associated with telomere shortening in HSCs and their progeny, even though increased production of ROS was associated with a significant reduction in HSC quiescence and an increase in HSC proliferation after TBI. Similar results were also observed recently in senescent HSCs from Atm-mutated mice. 21 Alternatively, ROS may mediate IR-induced premature senescence of HSCs via activation of the p38-p16 pathway. It has been shown that p38 plays an important role in regulating HSC self-renewal and activation of p38 by oxidative stress can mediate induction of HSC senescence in Atm mutants and FoxO3 KO mice via upregulation of p16. 21, 36 Our previous studies showed that activation of p38 was involved in IR-induced BM hematopoietic cell senescence and dysfunction. 30, 40 However, the present study showed that induction of HSC senescence by IR was independent of p16, because knockout of p16 in mice had no significant effects on TBI-induced HSC senescence and residual BM suppression. Furthermore, the lack of effect of p16 deletion cannot be attributed to compensation by Arf, because HSCs from irradiated Arf and p16/Arf KO mice exhibited changes similar to those seen in the cells from WT mice after TBI. The finding that IR induced HSC senescence and residual BM suppression in a p16 and Arf-independent manner is intriguing, because upregulation of p16 and Arf has been implicated in mediating induction of HSC senescence in a variety of pathological conditions and during aging, 8, 41, 42 and it has been shown that IR induced senescence in BM stromal cells in a p16-and Arf-dependent manner. 32 Furthermore, early T lymphoid progenitors are exquisitely dependent on CDK4/6 activity and, therefore, are very sensitive to p16 upregulation for induction of senescence during Figure 6 ), although p18 can also negatively regulate HSC selfrenewal. 49 Nor was the expression of p27 and p57 significantly elevated by TBI in HSCs from the KO mice. Instead, a more than 80-fold increase in the expression of p15 Ink4b (p15) mRNA was observed in HSCs from irradiated p16/Arf KO mice, whereas a less than 10-fold increase in p15 mRNA expression was detected in HSCs from irradiated WT mice, compared to the cells from control animals (Supplemental Figure 6) . It has been shown that p15, encoded by the p15 gene adjacent to the p16-Arf locus, assumes a significant role in tumor suppression by mediating oncogenic stress-induced senescence in the absence of p16. 50 Therefore, it will be of a great interest to determine whether p15 can function as a substitute for p16 to mediate TBI-induced HSC senescence in p16/Arf KO mice when Cdkn2ab -/-mice that are deficient for p15, p16 and Arf expression become available for our study in the future.
For personal use only. on May 29, 2017. by guest www.bloodjournal.org From In summary, the results from this study provides important new insights into the mechanism by which IR causes long-term BM suppression via induction of premature senescence of HSCs in a p16-Arf independent manner. A better understanding of the mechanism will allow us to develop new interventions to circumvent IR-induced long-term toxicity to BM via molecularly targeted inhibition of IR-induced HSC senescence, providing that the interventions do not cause increased risk of tumorigenesis. Because some chemotherapeutic agents can also induces HSC senescence and residual BM injury, these interventions may also benefit cancer patients undergoing chemotherapy. repopulating ability by CRA as described in Figure 2B . Percentages of total donor-derived (CD45.2) hematopoietic cells in peripheral blood of the recipients and percentages of T-, B-, and myeloid (M) cells in donor-derived hematopoietic cells in the peripheral blood of recipients are presented as mean ± SD (n=9 to 10 recipients from two independent experiments). ***p<0.001, TBI vs. CTL. (F) Repopulating units (RU) calculated according to the engraftment data presented in (E) are presented as mean ± SD. ***p<0.001, TBI vs. CTL.
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